Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

You are here: Home » News & Analysis

News & Analysis

Print

China biotech company and industry news and analysis...

Recent Articles

  Digital China Joins State-Owned Enterprises for Big Data Healthcare
  Bristol-Myers Squibb's Oral, Interferon-free HCV Regimen Approved in China
  Cathay Fortune to Acquire Germany's Epigenomics for $186 Million
  China's BGI and Healthlink Invest and Make Deal with UK's Congenica
  Aslan Officially Announces $40 Million Taiwan IPO
  Shanghai's EpimAb Closes $25 Million A Round for Bi-Specifics
  Aslan to Start Global Phase III Trial of Lead Cancer Drug
  Zai Lab Acquires China Rights to Novel Antibiotic from Paratek
  HitGen Enters Drug Discovery Collaboration with Scripps Research Institute
  Denovo Acquires Global Rights to Depression Drug Candidate
 
Login